Rockwell Medical Inc. (DE) (RMTI)
$8.04
$0.09
(1.07%)
As on 10-Sep-2026 16:00EDT
Market cap
$32 Mln
Revenue (TTM)
$69 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
22.1
-
Debt to Equity
0.2
-
Book Value
$--
-
EPS
$-1.3
-
Face value
--
-
Shares outstanding
4,030,465
10 Years Aggregate
CFO
$-183.23 Mln
EBITDA
$-216.32 Mln
Net Profit
$-240.66 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rockwell Medical Inc. (DE) (RMTI)
| -3.5 | 12.6 | 17.2 | -55.3 | -28.0 | -34.9 | -36.7 |
|
BSE Sensex*
| -11.8 | -4.9 | 0.9 | -8.3 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Rockwell Medical Inc. (DE) (RMTI)
| -59.1 | 7.9 | 86.2 | -59.4 | -58.6 | 8.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Rockwell Medical Inc. (DE) (RMTI)
|
8.0 | 32.2 | 69.4 | -5.1 | -5.7 | -14.1 | -- | 0.9 |
| 82.8 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 261.2 | 17,746.8 | 1,054.4 | 755.9 | 5.7 | -- | 20.9 | 10.5 | |
| 73.6 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 57.4 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 107.0 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 345.6 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 117.0 | 9,761.1 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.5 | |
| 533.1 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 583.2 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 |
Shareholding Pattern
View DetailsAbout Rockwell Medical Inc. (DE) (RMTI)
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate,... dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Read more
-
President, CEO & Director
Dr. Mark Strobeck Ph.D.
-
President, CEO & Director
Dr. Mark Strobeck Ph.D.
-
Headquarters
Wixom, MI
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Rockwell Medical Inc. (DE) (RMTI)
What is the current share price of Rockwell Medical Inc (DE) (RMTI) Today?
The share price of Rockwell Medical Inc (DE) (RMTI) is $8.04 (NASDAQ) as of 10-Sep-2026 16:00 EDT. Rockwell Medical Inc (DE) (RMTI) has given a return of -27.95% in the last 3 years.
What is the current PB & PE ratio of Rockwell Medical Inc (DE) (RMTI)?
Since, TTM earnings of Rockwell Medical Inc (DE) (RMTI) is negative, P/E ratio is not available.
The P/B ratio of Rockwell Medical Inc (DE) (RMTI) is 0.93 times as on 04-Sep-2026, a 83 discount to its peers’ median range of 5.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.62 |
0.09 |
2024 |
-13.97 |
0.21 |
2023 |
-0.64 |
0.25 |
2022 |
-0.06 |
0.08 |
2021 |
-1.18 |
15.20 |
What is the 52 Week High and Low of Rockwell Medical Inc (DE) (RMTI)?
The 52-week high and low of Rockwell Medical Inc (DE) (RMTI) are Rs 18.40 and Rs 4.89 as of 11-Sep-2026.
What is the market cap of Rockwell Medical Inc (DE) (RMTI)?
Rockwell Medical Inc (DE) (RMTI) has a market capitalisation of $ 32 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Rockwell Medical Inc (DE) (RMTI)?
Before investing in Rockwell Medical Inc (DE) (RMTI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.